Search results
Author(s):
Justin Hayase
,
Duc H Do
,
Noel G Boyle
Added:
3 years ago
The ICD is an important therapy for both primary and secondary prevention of sudden cardiac death in selected patients. The role for defibrillation threshold (DFT) testing either intraoperatively or postoperatively has changed significantly over the past few decades, and it is no longer routinely recommended in patients undergoing left-sided transvenous ICD implantation.1–7 The definition of the…
View more
Author(s):
Michael Timothy Brian Pope
,
John Paisey
,
Paul Richard Roberts
Added:
11 months ago
Author(s):
Dietmar Bänsch
Added:
3 years ago
For more than three decades, the implantable cardioverter defibrillator (ICD) has proven to be a well-established, main therapeutic tool for the primary and secondary prevention of sudden cardiac death due to malignant ventricular arrhythmias.1
One of the standard practice concepts is defibrillation (DF) testing. Defibrillation testing has been considered a mandatory part at the time of…
View more
Author(s):
Jaber Abboud
,
Joachim R Ehrlich
Added:
3 years ago
Implantable cardioverter defibrillators (ICDs) have been used for over 30 years to prevent sudden cardiac death (SCD). The first indications for ICD placement were secondary prevention; later trials demonstrated a primary prevention benefit of ICD therapy in patients at risk of SCD. ICD therapy prolongs life in both patient populations.1 However, the efficacy of an ICD depends on its ability to…
View more
Jeff Healey
Author
Author(s):
Marco Bergonti
Added:
11 months ago
EHRA 23 - Dr Marco Bergonti (Istituto Cardiocentro Ticino, CH) to discuss the key takeaways from the ANTWOORD II Trial.
In this study, 605 heart failure patients undergoing atrial fibrillation ablation were enrolled to receive an ANTWERP Score, which aimed to predict LVEF recovery. 70% of patients were categorised as 'responders', patients identified as those who could benefit the most from AF…
View more
Author(s):
Sanjiv M Narayan
,
Hugh Calkins
,
Andrew Grace
,
et al
Added:
1 year ago
Author(s):
Ahmadreza Karimianpour
,
Leah John
,
Michael R Gold
Added:
2 years ago
Author(s):
Hussam Ali
,
Pierpaolo Lupo
,
Riccardo Cappato
Added:
3 years ago
Numerous large clinical trials have demonstrated the benefit of implantable cardioverter-defibrillators (ICDs) to prevent sudden cardiac death (SCD) in selected populations.1,2 These results and advances in defibrillation therapies have led to an impressive expansion of ICD implants and indications in recent decades. Although initially focusing on secondary prevention, current ICD indications…
View more
Author(s):
Fouad Khalil
,
Konstantinos C Siontis
,
Gabor Bagameri
,
et al
Added:
3 years ago
Catheter-based ablation has been a well-established tool in the treatment of ventricular tachycardia (VT). However, the effectiveness of catheter ablation may be limited by its ability to access sites of arrhythmogenic tissue and achieve adequate lesion size in target areas without risking collateral damage. Antiarrhythmic surgery would be an effective alternative in such situations. Despite the…
View more